0001237899-20-000037.txt : 20200831 0001237899-20-000037.hdr.sgml : 20200831 20200831163500 ACCESSION NUMBER: 0001237899-20-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200828 FILED AS OF DATE: 20200831 DATE AS OF CHANGE: 20200831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POON CHRISTINE A CENTRAL INDEX KEY: 0001189014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201151917 MAIL ADDRESS: STREET 1: C/O JOHNSON & JOHNSON STREET 2: ONE JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-08-28 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001189014 POON CHRISTINE A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-08-28 4 M 0 15000 33.42 A 16433 D Common Stock 2020-08-28 4 M 0 25000 25.45 A 41433 D Common Stock 2020-08-28 4 S 0 177 598.91 D 41256 D Common Stock 2020-08-28 4 S 0 5730 599.67 D 35526 D Common Stock 2020-08-28 4 S 0 12490 600.44 D 23036 D Common Stock 2020-08-28 4 S 0 8011 601.53 D 15025 D Common Stock 2020-08-28 4 S 0 12899 602.39 D 2126 D Common Stock 2020-08-28 4 S 0 693 603.2 D 1433 D Non-Qualified Stock Option (right to buy) 25.45 2020-08-28 4 M 0 25000 0.0 D 2020-11-12 Common Stock 25000 0 D Non-Qualified Stock Option (right to buy) 33.42 2020-08-28 4 M 0 15000 0.0 D 2021-01-03 Common Stock 15000 0 D Represents volume-weighted average price of sales of 177 shares of Company stock on August 28, 2020 at prices ranging from $598.90 to $598.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price. Represents volume-weighted average price of sales of 5,730 shares of Company stock on August 28, 2020 at prices ranging from $599.00 to $599.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price. Represents volume-weighted average price of sales of 12,490 shares of Company stock on August 28, 2020 at prices ranging from $600.00 to $600.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price. Represents volume-weighted average price of sales of 8,011 shares of Company stock on August 28, 2020 at prices ranging from $601.00 to $601.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price. Represents volume-weighted average price of sales of 12,899 shares of Company stock on August 28, 2020 at prices ranging from $602.00 to $602.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price. Represents volume-weighted average price of sales of 693 shares of Company stock on August 28, 2020 at prices ranging from $603.00 to $603.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2020 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Christine A. Poon 2020-08-31